JP2005187030A - Flexible multi-chamber container - Google Patents

Flexible multi-chamber container Download PDF

Info

Publication number
JP2005187030A
JP2005187030A JP2003432936A JP2003432936A JP2005187030A JP 2005187030 A JP2005187030 A JP 2005187030A JP 2003432936 A JP2003432936 A JP 2003432936A JP 2003432936 A JP2003432936 A JP 2003432936A JP 2005187030 A JP2005187030 A JP 2005187030A
Authority
JP
Japan
Prior art keywords
chamber
flexible multi
covering means
chamber container
covering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003432936A
Other languages
Japanese (ja)
Other versions
JP4273962B2 (en
Inventor
Hiroyuki Higashimoto
浩幸 東元
Mitsuru Hasegawa
長谷川  満
Masanobu Iwasa
昌暢 岩佐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Priority to JP2003432936A priority Critical patent/JP4273962B2/en
Publication of JP2005187030A publication Critical patent/JP2005187030A/en
Application granted granted Critical
Publication of JP4273962B2 publication Critical patent/JP4273962B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Package Specialized In Special Use (AREA)
  • Tubes (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To prevent a medicine stored in a flexible multi-chamber container from being given to a patient before mixture. <P>SOLUTION: The flexible multi-chamber container 1 includes a container body 2 consisting of an upper chamber 10 and a lower chamber 20 sectioned via a partitioning means 30 capable of communicating when needed, and a discharge port 40 provided on the lower chamber 20. At least part of the surface of the lower chamber 20 is covered with a cover means 50. The cover means 50 is made in a structure separably connected via a connection 70 with a sealing means 60 for sealing a part 41 to be pierced of the discharge port 40. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は可撓性複室容器に関する。さらに詳しくは、室の一部を被覆する被覆手段と、排出口を封止する封止手段どうしが互いに接続された可撓性複室容器に関する。   The present invention relates to a flexible multi-chamber container. More specifically, the present invention relates to a flexible multi-chamber container in which a covering means for covering a part of a chamber and a sealing means for sealing a discharge port are connected to each other.

混合した状態では不安定な薬剤どうしを1つの容器内に分離して保存しておき、使用直前に無菌的に混合して使用する薬剤容器が近年普及している。このような薬剤容器としては、プラスチック等からなる可撓性フィルムにより容器を形成し、その内部を押圧により連通可能な弱シール部により区画してなる可撓性複室容器がよく知られている(例えば特許文献1参照)。   In recent years, drug containers have been widely used in which unstable drugs in a mixed state are separated and stored in a single container and used aseptically before use. As such a drug container, a flexible multi-chamber container is well known in which a container is formed by a flexible film made of plastic or the like, and the inside thereof is partitioned by a weak seal portion capable of communicating by pressing. (For example, refer to Patent Document 1).

しかし特許文献1のような容器は弱シールの連通を行わなくとも薬剤の排出が可能なため、弱シールの連通を忘れた場合には混合前の薬剤を患者に投与してしまうおそれがある。特に病床数の多い病院では、調剤部において薬剤師等が可撓性複室容器の混合操作を行うことがあるため、ベッドサイドの看護師等は排出口の被穿刺部を封止する封止手段(例えば、タンパーシール)を剥がす作業のみを行うことが多い。そのため調剤部で混合操作を行っていないと、臨床現場で混合作業を行うことなく未混合の薬剤が患者に投与されるおそれがある。   However, since a container such as Patent Document 1 can discharge a medicine without performing weak seal communication, there is a possibility that the medicine before mixing may be administered to a patient if the weak seal communication is forgotten. Especially in hospitals with a large number of beds, pharmacists and the like may perform mixing operations on flexible multi-chamber containers in the dispensing section, so bedside nurses and the like can use sealing means to seal the puncture site of the discharge port. In many cases, only the operation of peeling off (for example, the tamper seal) is performed. Therefore, if the mixing operation is not performed in the dispensing unit, there is a possibility that an unmixed drug is administered to the patient without performing a mixing operation at the clinical site.

そこで確実に弱シール部を連通させ、複数の室に収容されている薬剤を混合するための注意喚起効果を奏する可撓性複室容器が考案されている(特許文献2参照)。特許文献2の考案は容器のハンガー孔を薬剤の混合を促す表示部を有する開封確認用シールで塞ぐというものである。   In view of this, a flexible multi-chamber container has been devised in which a weak seal portion is surely communicated and an alerting effect for mixing medicines contained in a plurality of chambers is achieved (see Patent Document 2). The idea of Patent Document 2 is to close a hanger hole of a container with a seal for confirmation of opening having a display portion that prompts mixing of a medicine.

特開平2−4671号公報JP-A-2-4671 実用新案登録第3074885号公報Utility Model Registration No. 3074885

しかしながら特許文献2の考案では未混合投与を防ぐには十分でない。なぜならばハンガー孔の一般的な直径は余り大きくないため、そのハンガー孔を塞ぐシールも必然的に小さなものとなる。従って連通前にその小さなシールを喪失してしまった場合、従来と同様に未混合投与が行われるおそれが高い。また薬剤を収容した可撓性複室容器はハンガーに吊り下げないで使用されることもあるため(例えば容器内の薬剤をシリンジ等により吸引して使用する場合である)、このような場合にもやはり未混合投与が行われるおそれが高い。   However, the device of Patent Document 2 is not sufficient to prevent unmixed administration. This is because the general diameter of the hanger hole is not so large, and the seal for closing the hanger hole is inevitably small. Therefore, if the small seal is lost before communication, there is a high possibility that unmixed administration is performed as in the conventional case. In addition, since the flexible multi-chamber container containing the medicine may be used without being hung on the hanger (for example, when the medicine in the container is sucked with a syringe or the like), in such a case However, there is a high risk of unmixed administration.

そこで本発明者らは前記した課題を解決すべく鋭意研究を重ねた結果、本発明に想到した。すなわち本発明は、
(1) 内部に薬剤を収容する複数の室と、
該室同士を区画し且ついずれかの室を押圧することにより連通する仕切手段と、
前記薬剤を排出する排出口と、
該排出口の被穿刺部を封止する封止手段とを備えた可撓性複室容器であって、
前記室の少なくとも1つは該室の外表面の少なくとも一部分を被覆する取り外し可能な被覆手段を有するとともに、該被覆手段と前記封止手段とは分離可能な接続部により接続される可撓性複室容器。
(2) 前記被覆手段は前記排出口を設けた室を被覆するとともに、該室を押圧することにより前記接続部が分離する前記(1)に記載の可撓性複室容器。
(3) 前記被覆手段には薬剤の混合を促す旨の注意表示部が設けられてなる前記(1)または(2)に記載の可撓性複室容器。
(4) 前記被覆手段は前記室に設けられた内容物表示部の少なくとも一部分を隠蔽する前記(1)〜(3)の何れかに記載の可撓性複室容器。
(5) 前記被覆手段は前記室に剥離可能に接着または溶着される前記(1)〜(4)の何れかに記載の可撓性複室容器。
(6) 前記接続部はミシン目である前記(1)〜(5)の何れかに記載の可撓性複室容器。
(7) 前記被覆手段と前記封止手段が可撓性フィルムにより一体的に形成されてなる前記(6)記載の可撓性複室容器。
Therefore, the present inventors have come up with the present invention as a result of intensive studies to solve the above-mentioned problems. That is, the present invention
(1) A plurality of chambers for storing medicines inside,
Partition means for partitioning the chambers and communicating with each other by pressing one of the chambers;
An outlet for discharging the medicine;
A flexible multi-chamber container provided with sealing means for sealing the puncture portion of the discharge port,
At least one of the chambers has removable covering means for covering at least a portion of the outer surface of the chamber, and the covering means and the sealing means are connected by a flexible connection. Chamber container.
(2) The flexible multi-chamber container according to (1), wherein the covering means covers the chamber provided with the discharge port, and the connecting portion is separated by pressing the chamber.
(3) The flexible multi-chamber container according to (1) or (2), wherein the covering means is provided with a caution display section for prompting mixing of the medicine.
(4) The flexible multi-chamber container according to any one of (1) to (3), wherein the covering means conceals at least a part of a content display unit provided in the chamber.
(5) The flexible multi-chamber container according to any one of (1) to (4), wherein the covering means is detachably bonded or welded to the chamber.
(6) The flexible multi-chamber container according to any one of (1) to (5), wherein the connection portion is a perforation.
(7) The flexible multi-chamber container according to (6), wherein the covering means and the sealing means are integrally formed of a flexible film.

本発明によれば、可撓性複室容器に収容された薬剤が、混合前の状態で患者に投与されることを簡単な部材で防止することができる。   ADVANTAGE OF THE INVENTION According to this invention, it can prevent with the simple member that the chemical | medical agent accommodated in the flexible multi-chamber container is administered to a patient in the state before mixing.

次に、本発明の実施例を図面に基づいて説明する。
図1は本発明の実施例を示す正面図である。
図2は図1の背面図である。
図3は図1の右側面図である。
図4は図1の底面図である。図4の(a)は被穿刺部が封止手段で封止されている状態を示し、図4の(b)は封止手段を取り除いた状態を示す。
図5は本発明の実施例を示す正面図であり、薬剤を混合し被覆手段を取り除いた後の状態を示す。
図6は本発明の実施例の使用状況を示す図である。
Next, embodiments of the present invention will be described with reference to the drawings.
FIG. 1 is a front view showing an embodiment of the present invention.
FIG. 2 is a rear view of FIG.
FIG. 3 is a right side view of FIG.
FIG. 4 is a bottom view of FIG. 4A shows a state where the puncture portion is sealed with the sealing means, and FIG. 4B shows a state where the sealing means is removed.
FIG. 5 is a front view showing an embodiment of the present invention, and shows a state after the medicine is mixed and the covering means is removed.
FIG. 6 is a diagram showing a use situation of the embodiment of the present invention.

図1〜4に示すように本発明の可撓性複室容器1は、用時連通可能な仕切手段30を介して区画された上室10および下室20からなる容器本体2と下室20に設けられた排出口40を含んでなり、下室20の表面の少なくとも一部分は被覆手段50により被覆されるとともに、この被覆手段50は排出口40の被穿刺部41を封止する封止手段60に接続部70を介して分離可能に接続された構成よりなる。   As shown in FIGS. 1 to 4, the flexible multi-chamber container 1 of the present invention includes a container main body 2 and a lower chamber 20 that are composed of an upper chamber 10 and a lower chamber 20 that are partitioned by a partition means 30 that can communicate with each other. And at least a part of the surface of the lower chamber 20 is covered with the covering means 50, and the covering means 50 is a sealing means for sealing the puncture portion 41 of the discharge port 40. 60 is configured to be separably connected to 60 through a connection unit 70.

容器本体2は可撓性フィルムよりなり、その内部は用時連通可能な仕切手段30を介して薬剤D1を収容する上室10と薬剤D2を収容する下室20とにそれぞれ区画されるとともに、その周囲は液密または気密にシールされる。シール方法としては熱溶着、超音波溶着、接着等が挙げられるが、内部を液密または気密に保つことができるならばそのシール方法は限定されない。また、容器本体2の形成材料としては例えばポリエチレンおよびポリプロピレン等のポリオレフィン樹脂、ポリ塩化ビニル、PET(ポリエチレンテレフタレート)、EVA(エチレン酢酸ビニル共重合体)、EVOH(エチレンビニルアルコール共重合体)、ポリアミド、ポリビニリデンクロライド、ポリビニルフルオライド、ポリトリフルオルクロルエチレン、ポリエステル、ナイロン、それらの混合物、それらの積層体が挙げられるが、医療用材料としての使用実績があり容器本体2内に収容される薬剤と相互作用せず薬剤への溶出等のおそれがなければいずれも好適に採用できる。本実施例では薬剤D1およびD2は両方とも液剤であるが、どちらか一方が粉剤であってもよい。なお、後述するように仕切手段30が室の押圧により連通する弱シールの場合には、少なくとも1つの室には液剤が収容されていることが好ましい。これは、液剤を収容した室を押圧することにより、弱シールを連通させるのに必要な圧力を発生させるためである。   The container body 2 is made of a flexible film, and the inside thereof is divided into an upper chamber 10 that stores the drug D1 and a lower chamber 20 that stores the drug D2 through partition means 30 that can communicate with each other. Its surroundings are sealed liquid-tight or air-tight. Examples of the sealing method include thermal welding, ultrasonic welding, adhesion, and the like, but the sealing method is not limited as long as the inside can be kept liquid-tight or air-tight. Examples of the material for forming the container body 2 include polyolefin resins such as polyethylene and polypropylene, polyvinyl chloride, PET (polyethylene terephthalate), EVA (ethylene vinyl acetate copolymer), EVOH (ethylene vinyl alcohol copolymer), and polyamide. , Polyvinylidene chloride, polyvinyl fluoride, polytrifluorochloroethylene, polyester, nylon, mixtures thereof, and laminates thereof, but have been used as medical materials and are contained in the container body 2 Any of them can be suitably used as long as there is no risk of elution into the drug without interacting with the drug. In this embodiment, both the drugs D1 and D2 are liquids, but either one may be a powder. As will be described later, when the partitioning means 30 is a weak seal that communicates with the chamber by pressing, it is preferable that at least one chamber contains a liquid agent. This is to generate a pressure necessary for communicating the weak seal by pressing the chamber containing the liquid agent.

仕切手段30は弱シールにより形成され、上室10または下室20を押圧したときに連通する。弱シール方法としては容器本体2を形成する樹脂と相溶性の小さい樹脂からなるシートを間に挟みこんで溶着する等の方法が挙げられる。例えば容器本体2がポリエチレン系の樹脂からなる場合、ポリエチレンと相溶性を持たないポリプロピレン等の樹脂からなるシートを間に挟み込んで溶着することにより、そのシール部分は比較的容易に剥離可能な弱シールとすることができる。なおこのような方法以外にも特許文献1に記載された方法や破断可能な有底筒等を介装する方法も採用可能であり、仕切手段30が用時連通可能であるならばその方法は特に限定されない。   The partition means 30 is formed by a weak seal and communicates when the upper chamber 10 or the lower chamber 20 is pressed. Examples of the weak sealing method include a method in which a sheet made of a resin having a low compatibility with the resin forming the container main body 2 is sandwiched and welded. For example, when the container body 2 is made of a polyethylene resin, a weak seal that can be peeled relatively easily by sandwiching and welding a sheet made of a resin such as polypropylene that is not compatible with polyethylene. It can be. In addition to such a method, a method described in Patent Document 1 or a method of interposing a breakable bottomed tube can be employed. If the partitioning means 30 can be communicated in use, the method is as follows. There is no particular limitation.

下室20には混合後の薬剤を排出したりさらに他の薬剤を容器本体2内に注入する際に利用される排出口40が設けられる。図4の(b)に示すように排出口40には輸液針や注射針が穿刺される被穿刺部41が設けられており、この被穿刺部41は使用直前まで封止手段60により液密または気密に封止されている。封止手段60は被穿刺部41が製造時における清浄性を保つようにするともに、可撓性複室容器1が未使用であることを証明する。排出口40の形成材料としては例えばポリエチレンおよびポリプロピレン、環状ポリオレフィン等のポリオレフィン樹脂、ポリ塩化ビニル、PET、EVA、EVOH、ポリアミド、ポリビニリデンクロライド、ポリビニルフルオライド、ポリトリフルオルクロルエチレン、ポリエステル、ナイロン、ポリスチレン、ABS樹脂、ポリカーボネート、メタクリル樹脂、ポリメチルペンテン、それらの混合物、それらの積層体等が挙げられるが、医療用材料としての使用実績があり容器本体2内に収容される薬剤と相互作用せず薬剤への溶出等のおそれがなければいずれも好適に採用できる。被穿刺部41の形成材料としては例えばブチルゴム、シリコンゴム、熱可塑性エラストマー、シリコンエラストマー等の弾性材料が好適に採用可能であるが、輸液針や注射針を穿刺することができるならば特に限定されない。   The lower chamber 20 is provided with a discharge port 40 that is used when discharging the mixed drug or injecting another drug into the container body 2. As shown in FIG. 4B, the discharge port 40 is provided with a puncture portion 41 into which an infusion needle or an injection needle is punctured. The puncture portion 41 is liquid-tight by the sealing means 60 until just before use. Or it is sealed hermetically. The sealing means 60 ensures that the portion to be punctured 41 is kept clean during manufacture and proves that the flexible multi-chamber container 1 is unused. Examples of the material for forming the discharge port 40 include polyolefin resins such as polyethylene and polypropylene, cyclic polyolefin, polyvinyl chloride, PET, EVA, EVOH, polyamide, polyvinylidene chloride, polyvinyl fluoride, polytrifluoroethylene, polyester, nylon, Examples include polystyrene, ABS resin, polycarbonate, methacrylic resin, polymethylpentene, mixtures thereof, and laminates thereof. However, they have been used as medical materials and interact with drugs contained in the container body 2. Any of them can be suitably employed as long as there is no fear of elution into the drug. For example, elastic material such as butyl rubber, silicone rubber, thermoplastic elastomer, silicone elastomer or the like can be suitably used as a material for forming the portion 41 to be punctured, but is not particularly limited as long as it can puncture an infusion needle or injection needle. .

図1〜4に示す封止手段60は可撓性フィルムであり、熱溶着、超音波溶着、接着等により排出口40に取り付けられるが、被穿刺部41を液密または気密に封止可能であればその取り付け方法は特に限定されない。また図6の(c)に示すように、封止手段60を排出口40から取り除く際には、つまみ部61をつまんで矢印C方向に引き剥がすとやり易い。封止手段60の形成材料としては例えばポリエチレンおよびポリプロピレン等のポリオレフィン樹脂、ポリ塩化ビニル、PET、EVA、EVOH、ポリアミド、ポリビニリデンクロライド、ポリビニルフルオライド、ポリトリフルオルクロルエチレン、ポリエステル、ナイロン、ポリ塩化ビニリデン、ポリビニルアルコール、それらの混合物、それらの積層体等が挙げられるが、可撓性を有する樹脂であれば特に限定されない。   The sealing means 60 shown in FIGS. 1 to 4 is a flexible film and is attached to the discharge port 40 by heat welding, ultrasonic welding, adhesion, or the like, but the puncture portion 41 can be sealed in a liquid-tight or air-tight manner. If it exists, the attachment method will not be specifically limited. Also, as shown in FIG. 6C, when removing the sealing means 60 from the discharge port 40, it is easy to pinch the knob portion 61 and peel it off in the direction of arrow C. Examples of the forming material of the sealing means 60 include polyolefin resins such as polyethylene and polypropylene, polyvinyl chloride, PET, EVA, EVOH, polyamide, polyvinylidene chloride, polyvinyl fluoride, polytrifluoroethylene, polyester, nylon, and polychlorinated. Examples thereof include vinylidene, polyvinyl alcohol, a mixture thereof, a laminate thereof, and the like, but are not particularly limited as long as the resin has flexibility.

下室20の外表面には、その外表面の少なくとも一部分を被覆する被覆手段50が剥離可能に貼着されている。その貼着方法としては、接着、溶着が挙げられるが被覆手段50が剥離可能であるならばその方法は特に限定されない。また被覆手段50は下室20の片面の略全部を被覆してもよい。被覆手段50の形成材料としては、封止手段60と同じものが好適に採用可能であり、デラミネーション(層間剥離)可能なフィルムであってもよい。被覆手段50に相関剥離可能なフィルムを採用することにより、被覆手段50を取り去る際に被覆手段50の一部の層は下室20に残ることになる。この層に例えば「開封済み」等の文字を印字しておき、この文字を取り去られる層により隠蔽しておくこともできる。   A covering means 50 that covers at least a part of the outer surface of the lower chamber 20 is detachably attached to the outer surface of the lower chamber 20. Examples of the attaching method include adhesion and welding, but the method is not particularly limited as long as the covering means 50 can be peeled off. Further, the covering means 50 may cover substantially the entire one surface of the lower chamber 20. As the forming material of the covering means 50, the same material as that of the sealing means 60 can be suitably employed, and a film that can be delaminated (delaminated) may be used. By employing a film that can be peeled off as the covering means 50, a part of the layer of the covering means 50 remains in the lower chamber 20 when the covering means 50 is removed. For example, characters such as “opened” can be printed on this layer and concealed by a layer from which these characters can be removed.

また図1に示すように被覆手段50には使用時に薬剤D1およびD2の混合を促す旨の注意表示部80が設けられており、使用時には上室10または下室20のどちらか一方を押すことにより仕切手段30を連通させ、薬剤D1およびD2の混合操作を行うよう使用者に促す。図1の注意表示部80には「ここを押して薬剤混合」と表示されており、被覆手段50を押すことにより混合操作を行うよう注意を促しているが、使用時に混合操作を行う旨を視覚的に促すものであればその内容、手段は特に限定されず模式図であってもよい。   Further, as shown in FIG. 1, the covering means 50 is provided with a caution display section 80 for prompting the mixing of the medicines D1 and D2 during use, and either the upper chamber 10 or the lower chamber 20 is pushed during use. This causes the partition means 30 to communicate and prompts the user to perform the mixing operation of the drugs D1 and D2. In the caution display section 80 of FIG. 1, “Press here to mix medicine” is displayed, and the user is urged to perform the mixing operation by pressing the covering means 50. The contents and means are not particularly limited as long as they are urgently suggested, and may be schematic views.

また、図1および5に示すように下室20の外表面には内部に収容された薬剤の量や名称を表示する内容物表示部90が設けられており、被覆手段50はこの内容物表示部90の少なくとも一部分を隠蔽する。内容物表示部90は、混合薬剤を排出するときに薬剤の残量を表示する目盛り線91と容量を示す数字92からなる。内容物表示部90が隠蔽されていると使用者は薬剤の残量を知ることができないため、自然と内容物表示部90を隠蔽している被覆手段50に注意し混合操作を行う必要性を認識する。内容物表示部90は前述した目盛り線91と容量を示す数字92以外に、薬剤名、処方等の内部に収容する薬剤に関する情報を表示してもよい。また被覆手段は内容物表示手段90の略全てを隠蔽してもよい。   Further, as shown in FIGS. 1 and 5, a content display unit 90 is provided on the outer surface of the lower chamber 20 to display the amount and name of the medicine accommodated therein, and the covering means 50 displays the content display. At least a part of the portion 90 is concealed. The content display unit 90 includes a scale line 91 for displaying the remaining amount of the medicine when discharging the mixed medicine and a number 92 indicating the capacity. If the content display unit 90 is concealed, the user cannot know the remaining amount of the medicine. Therefore, it is necessary to pay attention to the covering means 50 that conceals the content display unit 90 and to perform a mixing operation. recognize. In addition to the scale line 91 and the number 92 indicating the capacity described above, the content display unit 90 may display information on the medicine accommodated in the medicine name, prescription, and the like. Further, the covering means may conceal substantially all of the content display means 90.

被覆手段50と封止手段60とは接続部70により接続されており、この接続部70は必要に応じて分離可能である。図1に示す被覆手段50と封止手段60は可撓性フィルムで一体的に形成されており、両者を接続する接続部70は被覆手段50と封止手段60の境界線上に形成されたミシン目である。なお接続部70は必ずしもミシン目である必要はなく、被覆手段50と封止手段60とが分離可能に接続されるならばその接続方法は特に限定されない。他の接続方法の例としては接着、溶着、係合等が挙げられる。   The covering means 50 and the sealing means 60 are connected by a connecting portion 70, and the connecting portion 70 can be separated as necessary. The covering means 50 and the sealing means 60 shown in FIG. 1 are integrally formed of a flexible film, and a connecting portion 70 that connects them is a sewing machine formed on the boundary line between the covering means 50 and the sealing means 60. Eyes. Note that the connecting portion 70 is not necessarily a perforation, and the connecting method is not particularly limited as long as the covering means 50 and the sealing means 60 are detachably connected. Examples of other connection methods include adhesion, welding, engagement, and the like.

次いで本発明の実施例の使用方法について図6を用いて説明する。
(1) 病床数の多い大きな病院では、まず図6の(a)に示すように調剤部にて薬剤師等が被覆手段50と一緒に下室20を矢印A方向に押圧することにより仕切手段30の弱シールを連通し、薬剤D1と薬剤D2との混合操作を行う。この混合操作を行うときに被覆手段50が押されるのに伴って接続部70が引っ張られ、接続部70はミシン目で破断する。接続部70が破断しているか否かを確認することにより薬剤の混合が完了しているか否かを知ることができる。なお接続部70は混合操作を行うと同時に分離する必要は必ずしもなく、混合操作を行った後に分離するようになっていてもよい。
(2) 次いで図6の(b)に示すように被覆手段50を矢印B方向に引っ張って下室20から剥離する。この剥離操作は調剤部で行っても良いしベッドサイドで行っても良い。ただし調剤部の薬剤師が混合操作を行った後、被覆手段50を付けたままの状態でベッドサイドの看護師に渡されるならば、混合操作の有無について薬剤師、看護師双方による二重確認を行うことができる。
(3) 次いで図6の(c)に示すようにつまみ部61をつまんで封止手段60を矢印C方向に引っ張り排出口40から剥離する。しかる後に被穿刺部41(図示しない)を消毒し、輸液針等を穿刺し患者に混合薬剤を投与する。なお病床数の少ない小さな病院では全ての作業を看護師がベッドサイドで行うことが多い。
Next, a method of using the embodiment of the present invention will be described with reference to FIG.
(1) In a large hospital with a large number of hospital beds, first, as shown in FIG. 6A, a pharmacist or the like presses the lower chamber 20 in the direction of arrow A together with the covering means 50 at the dispensing unit 30. The weak seal is communicated, and the mixing operation of the drug D1 and the drug D2 is performed. When the mixing operation is performed, the connecting portion 70 is pulled as the covering means 50 is pushed, and the connecting portion 70 is broken at the perforation. It can be known whether or not the mixing of the medicine is completed by checking whether or not the connecting portion 70 is broken. The connecting portion 70 does not necessarily need to be separated at the same time as performing the mixing operation, and may be separated after performing the mixing operation.
(2) Next, as shown in FIG. 6 (b), the covering means 50 is pulled in the direction of arrow B to peel off from the lower chamber 20. This peeling operation may be performed at the dispensing part or at the bedside. However, if the pharmacist of the dispensing unit performs the mixing operation and is handed over to the bedside nurse with the covering means 50 attached, both the pharmacist and the nurse will double check whether or not the mixing operation is performed. be able to.
(3) Next, as shown in FIG. 6C, the knob 61 is pinched and the sealing means 60 is pulled in the direction of arrow C to peel off from the discharge port 40. Thereafter, the portion to be punctured 41 (not shown) is sterilized, and an infusion needle or the like is punctured to administer the mixed drug to the patient. In small hospitals with few beds, nurses often perform all work at the bedside.

ところで、混合操作を忘れ被覆手段50がそのまま残っているような場合には、封止手段60を取り除く際に、封止手段60に被覆手段50が接続されていることに自然に気付く。従って、何らかの異常(未混合)があることを看護師等の使用者は認識するため、混合前の薬剤投与を効果的に防止することができる。   By the way, when the mixing means is forgotten and the covering means 50 remains as it is, when removing the sealing means 60, it is naturally noticed that the covering means 50 is connected to the sealing means 60. Therefore, since a user such as a nurse recognizes that there is some abnormality (unmixed), it is possible to effectively prevent drug administration before mixing.

図1は本発明の実施例を示す正面図である。FIG. 1 is a front view showing an embodiment of the present invention. 図2は図1の背面図である。FIG. 2 is a rear view of FIG. 図3は図1の右側面図である。FIG. 3 is a right side view of FIG. 図4は図1の底面図である。図4の(a)は被穿刺部が封止手段で封止されている状態を示し、図4の(b)は封止手段を取り除いた状態を示す。FIG. 4 is a bottom view of FIG. 4A shows a state where the puncture portion is sealed with the sealing means, and FIG. 4B shows a state where the sealing means is removed. 図5は本発明の実施例を示す正面図であり、薬剤を混合し被覆手段を取り除いた後の状態を示す。FIG. 5 is a front view showing an embodiment of the present invention, and shows a state after the medicine is mixed and the covering means is removed. 図6は本発明の実施例の使用状況を示す図である。FIG. 6 is a diagram showing a use situation of the embodiment of the present invention.

符号の説明Explanation of symbols

1 可撓性複室容器
10、20 室(上室、下室)
30 仕切手段
40 排出口
41 被穿刺部
50 被覆手段
60 封止手段
70 接続部
80 注意表示部
90 内容物表示部
D1、D2 薬剤
1 Flexible multi-chamber container 10, 20 chambers (upper and lower chambers)
30 partition means 40 discharge port 41 puncture part 50 covering means 60 sealing means 70 connection part 80 attention display part 90 content display part D1, D2 medicine

Claims (7)

内部に薬剤を収容する複数の室と、
該室同士を区画し且ついずれかの室を押圧することにより連通する仕切手段と、
前記薬剤を排出する排出口と、
該排出口の被穿刺部を封止する封止手段とを備えた可撓性複室容器であって、
前記室の少なくとも1つは該室の外表面の少なくとも一部分を被覆する取り外し可能な被覆手段を有するとともに、該被覆手段と前記封止手段とは分離可能な接続部により接続される可撓性複室容器。
A plurality of chambers for containing medicines,
Partition means for partitioning the chambers and communicating with each other by pressing one of the chambers;
An outlet for discharging the medicine;
A flexible multi-chamber container provided with sealing means for sealing the puncture portion of the discharge port,
At least one of the chambers has removable covering means for covering at least a portion of the outer surface of the chamber, and the covering means and the sealing means are connected by a flexible connection. Chamber container.
前記被覆手段は前記排出口を設けた室を被覆するとともに、該室を押圧することにより前記接続部が分離する請求項1に記載の可撓性複室容器。   The flexible multi-chamber container according to claim 1, wherein the covering means covers the chamber provided with the discharge port, and the connecting portion is separated by pressing the chamber. 前記被覆手段には薬剤の混合を促す旨の注意表示部が設けられてなる請求項1または2に記載の可撓性複室容器。   The flexible multi-chamber container according to claim 1 or 2, wherein the covering means is provided with a caution display portion for prompting mixing of the medicine. 前記被覆手段は前記室に設けられた内容物表示部の少なくとも一部分を隠蔽する請求項1〜3の何れかに記載の可撓性複室容器。   The flexible multi-chamber container according to any one of claims 1 to 3, wherein the covering means conceals at least a part of a content display section provided in the chamber. 前記被覆手段は前記室に剥離可能に接着または溶着される請求項1〜4の何れかに記載の可撓性複室容器。   The flexible multi-chamber container according to any one of claims 1 to 4, wherein the covering means is detachably bonded or welded to the chamber. 前記接続部はミシン目である請求項1〜5の何れかに記載の可撓性複室容器。   The flexible multi-chamber container according to claim 1, wherein the connection portion is a perforation. 前記被覆手段と前記封止手段が可撓性フィルムにより一体的に形成されてなる請求項6記載の可撓性複室容器。
The flexible multi-chamber container according to claim 6, wherein the covering means and the sealing means are integrally formed of a flexible film.
JP2003432936A 2003-12-26 2003-12-26 Flexible multi-chamber container Expired - Fee Related JP4273962B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003432936A JP4273962B2 (en) 2003-12-26 2003-12-26 Flexible multi-chamber container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003432936A JP4273962B2 (en) 2003-12-26 2003-12-26 Flexible multi-chamber container

Publications (2)

Publication Number Publication Date
JP2005187030A true JP2005187030A (en) 2005-07-14
JP4273962B2 JP4273962B2 (en) 2009-06-03

Family

ID=34790479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003432936A Expired - Fee Related JP4273962B2 (en) 2003-12-26 2003-12-26 Flexible multi-chamber container

Country Status (1)

Country Link
JP (1) JP4273962B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007111181A (en) * 2005-10-19 2007-05-10 Ajinomoto Co Inc Medicament storage/sealing body and adhesive seal
JP2007135933A (en) * 2005-11-18 2007-06-07 Otsuka Pharmaceut Factory Inc Medical multi-chamber container
JP2007244660A (en) * 2006-03-16 2007-09-27 Terumo Corp Medical multi-chamber container
JP2009007008A (en) * 2007-01-25 2009-01-15 Toyo Seikan Kaisha Ltd Branch type pouch
WO2010010866A1 (en) * 2008-07-22 2010-01-28 株式会社モリモト医薬 Medicine container
US20130259407A1 (en) * 2007-08-16 2013-10-03 Ajinomoto Co., Inc. Process of fusion-bonding plastic film and drug bag

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007111181A (en) * 2005-10-19 2007-05-10 Ajinomoto Co Inc Medicament storage/sealing body and adhesive seal
JP2007135933A (en) * 2005-11-18 2007-06-07 Otsuka Pharmaceut Factory Inc Medical multi-chamber container
JP4619274B2 (en) * 2005-11-18 2011-01-26 株式会社大塚製薬工場 Medical multi-chamber container
JP2007244660A (en) * 2006-03-16 2007-09-27 Terumo Corp Medical multi-chamber container
JP4708234B2 (en) * 2006-03-16 2011-06-22 テルモ株式会社 Medical multi-chamber container
JP2009007008A (en) * 2007-01-25 2009-01-15 Toyo Seikan Kaisha Ltd Branch type pouch
US20130259407A1 (en) * 2007-08-16 2013-10-03 Ajinomoto Co., Inc. Process of fusion-bonding plastic film and drug bag
US9216554B2 (en) * 2007-08-16 2015-12-22 Ajinomoto Co., Inc. Process of fusion-bonding plastic film and drug bag
WO2010010866A1 (en) * 2008-07-22 2010-01-28 株式会社モリモト医薬 Medicine container

Also Published As

Publication number Publication date
JP4273962B2 (en) 2009-06-03

Similar Documents

Publication Publication Date Title
JP4930772B2 (en) Communicating needle used to communicate two or more containers
JP4697398B2 (en) Preparation kit for injection and syringe containing medicine
US20150196720A1 (en) Outer cylinder for prefilled syringe, piercing tool for prefilled syringe, prefilled syringe, and packaging body for packaging outer cylinder for prefilled syringe
JP6789154B2 (en) Medical container
JP4273962B2 (en) Flexible multi-chamber container
JP4920246B2 (en) Medical liquid container and medical liquid container with medicine
JP2003159309A (en) Container for infusion solution and die for forming drug container body
JP6817852B2 (en) Medical container
WO1999006089A1 (en) Medical container
JP2000070336A (en) Medicinal liquid storage container and medicinal liquid injecting set using the container
JP2000316951A (en) Medical bag for chemicals solution
JP2000005275A (en) Container for supplying infusion
JP3668293B2 (en) Injection container
JP3415714B2 (en) Chemical transfer device and chemical transfer system
JP2000107255A (en) Drug-mixing transfusion container
JP2001009006A (en) Double cell container
JPH04221567A (en) Medical container
WO2012043512A1 (en) Pre-filled syringe and individual pre-filled syringe packaging unit
JP2006141827A (en) Infusion tube, chemical solution delivery set and connecting adapter
JP6031114B2 (en) Prefilled syringe outer cylinder, puncture tool for prefilled syringe, and prefilled syringe
JP4606084B2 (en) Multi-chamber container
JPH0759865A (en) Injection container
JP2017148228A (en) Medicament-prestored soft medical container and medicament administration appliance
JP4930138B2 (en) Medical multi-chamber container
JP2000175987A (en) Double-chamber bag

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060613

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20081009

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081111

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090108

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090210

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090223

R150 Certificate of patent or registration of utility model

Ref document number: 4273962

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120313

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120313

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150313

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees